Clinical Trial Update: A Study of MF101 in Postmenopausal Women [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for MF101 in postmenopausal women assessing hot flashes and vasomotor symptoms, sponsored by Bionovo, with trial status currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menopause

Drugs mentioned

• MF101

Snippet

Sponsor: Bionovo | Conditions: Hot Flushes, Vasomotor Symptoms | Phase 3 | Status: UNKNOWN